Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | VRTX | GSK | ||
| Company | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 970.00 | 420.67 | 44.98 | ||
| High | 979.98 | 423.32 | 45.10 | ||
| Low | 966.85 | 417.50 | 44.80 | ||
| Last | 973.80 | 422.78 | 45.07 | ||
| Change | +5.80 | +3.79 | +0.40 | ||
| % Change | +0.60% | +0.90% | +0.90% | ||
| Volume | 351,300 | 1,064,500 | 3,771,079 | ||
| 20-Day Average Volume | 491,760 | 1,107,775 | 3,315,255 | ||
| Previous Close | 968.00 | 418.99 | 44.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 919.00 | 401.94 | 41.89 | ||
| 20-Day Raw Stochastic | 94.10% | 91.71% | 99.50% | ||
| 20-Day Relative Strength | 61.33% | 62.31% | 71.23% | ||
| Weighted Alpha | +31.48 | +22.92 | +30.07 | ||
| Today's Opinion | 72% Buy | 56% Buy | 88% Buy | ||
| Previous Opinion | 72% Buy | 56% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 24% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.76% since 05/03/24 | +5.41% since 05/03/24 | +3.61% since 05/03/24 | ||
| Low | 950.27 on 05/06/24 | 394.03 on 05/07/24 | 43.17 on 05/06/24 | ||
| High | 979.98 on 05/10/24 | 425.65 on 05/08/24 | 45.10 on 05/10/24 | ||
| 1-Month | |||||
| %Chg | +4.02% since 04/10/24 | +6.34% since 04/10/24 | +10.76% since 04/10/24 | ||
| Low | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.15 on 04/18/24 | ||
| High | 979.98 on 05/10/24 | 425.65 on 05/08/24 | 45.10 on 05/10/24 | ||
| 3-Month | |||||
| %Chg | +2.14% since 02/09/24 | -0.03% since 02/09/24 | +7.54% since 02/09/24 | ||
| Low | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.15 on 04/18/24 | ||
| High | 998.33 on 02/28/24 | 437.00 on 02/27/24 | 45.10 on 05/10/24 | ||
| 6-Month | |||||
| %Chg | +21.89% since 11/10/23 | +13.15% since 11/10/23 | +30.98% since 11/10/23 | ||
| Low | 784.96 on 11/15/23 | 341.90 on 11/16/23 | 34.29 on 11/16/23 | ||
| High | 998.33 on 02/28/24 | 448.40 on 01/30/24 | 45.10 on 05/10/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 106,249,616 | 108,121,632 | 92,575,888 | ||
| Shares Outstanding, K | 109,762 | 258,053 | 2,072,440 | ||
| Annual Sales | 13,117,200,000 | 9,869,200,000 | 37,725,000,000 | ||
| Annual Net Income | 3,953,600,000 | 3,619,600,000 | 6,129,940,000 | ||
| Last Quarter Sales | 3,145,000,000 | 2,517,700,000 | 9,337,020,000 | ||
| Last Quarter Net Income | 722,000,000 | 968,800,000 | 1,326,430,000 | ||
| 60-Month Beta | 0.17 | 0.39 | 0.65 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 9.55 on 05/02/24 | 4.76 on 05/06/24 | 1.09 on 05/01/24 | ||
| Latest Earnings Date | 05/02/24 | 05/06/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | N/A | 0.397 on 02/22/24 | ||
| Next Ex-Dividends Date | N/A | N/A | 05/16/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 25.75 | 27.81 | 10.93 | ||